Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib versus placebo with FOLFIRI in chemorefractory advanced gastric or lower esophageal adenocarcinoma
2009-014336-38Phase 2Completed
- Sponsor
- University Medical Center Mainz
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in gastric adenocarcinoma and esophageal adenocarcinoma (EAC) comparing Sunitinib + FOLFIRI with Placebo + FOLFIRI (2 arms). Primary endpoint: Progression-free survival. Started Aug 2009; status: completed.
02
Drugs
sunitinib
03
Conditions
gastric adenocarcinomaesophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on 2009-014336-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014336-38.